NOVARTIND

Healthcare Drug Manufacturers - Specialty & Generic

₹1845.0

+1.43% today · 30d -11.93%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for NOVARTIND. The deterministic sections below render from live data.

◇ Sector Position

PEERPEROCE %

NOVARTIND43.48—

SUNPHARMA37.7921.44

DIVISLAB93.121.56

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 100

Valuation FAIR 40

Growth STEADY 51

Profitability — —

Technicals NEUTRAL 67

Risk LOW 90

Key Stats

TTM PE

43.48

P/B

5.2

52W HIGH

₹2588.8

OFF HIGH

-28.73%

DIV YIELD

0.0%

MKT CAP

₹4597 Cr

◉ Active Signals

MACDNeutral4.2034

RSI(14)Neutral51.8

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NOVARTIND and at what entry.